Document:

Exhibit 10.36

 

NEITHER
THIS NOTE NOR THE SECURITIES INTO WHICH THIS NOTE IS CONVERTIBLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE
COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE. THESE SECURITIES HAVE BEEN SOLD IN RELIANCE UPON AN EXEMPTION FROM
REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY,
MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT
TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND
IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS.

 

Electromedical
Technologies, Inc.

 

Convertible
Note

 

	Issuance Date: June 4,
    2020	Original
    Principal Amount:        $110,000
	Note No. ELCQ-1	Consideration Paid
    at Close:       $100,000

 

FOR
VALUE RECEIVED, Electromedical Technologies, Inc., a Delaware corporation with a par value of $0.001 per common
share (“Par Value”) (the "Company"), hereby promises to pay to the order of Vista Capital
Investments, LLC or registered assigns (the "Holder") the amount set out above as the Original Principal
Amount (as reduced pursuant to the terms hereof pursuant to redemption, conversion or otherwise, the
 "Principal") when due, whether upon the Maturity Date (as defined below), acceleration, redemption or
otherwise (in each case in accordance with the terms hereof) and to pay interest ("Interest") on any
outstanding Principal at the applicable Interest Rate from the date set out above as the Issuance Date (the "Issuance
Date") until the same becomes due and payable, upon the Maturity Date or acceleration, conversion, redemption or
otherwise (in each case in accordance with the terms hereof).

 

The
Original Principal Amount is $110,000 (one hundred ten thousand) plus accrued and unpaid interest and any other fees. The
Consideration is $100,000 (one hundred thousand) payable by wire transfer (there exists a $10,000 original issue discount
(the “OID”)). The Holder shall pay $100,000 of Consideration upon closing of this Note. For purposes hereof, the
term “Outstanding Balance” means the Original Principal Amount, as reduced or increased, as the case may be,
pursuant to the terms hereof for conversion, breach hereof or otherwise, plus any accrued but unpaid interest, collection and
enforcements costs, and any other fees, penalties, damages or charges incurred under this Note.

 

		(1)	GENERAL TERMS

 

 (a)           Payment of Principal. The "Maturity Date" shall be December 15, 2020, and may be extended at the option of the Holder in the event that, and for so long as, an Event of Default (as defined below) shall not have occurred and be continuing on the Maturity Date (as may be extended pursuant to this Section 1) or any event shall not have occurred and be continuing on the Maturity Date (as may be extended pursuant to this Section 1) that with the passage of time and the failure to cure would result in an Event of Default.

 

 (b)           Interest. A one-time interest charge of eight percent (8%) (“Interest Rate”) shall be applied on the Issuance Date to the Outstanding Balance. Interest hereunder shall be paid on the Maturity Date (or sooner as provided herein) to the Holder or its assignee in whose name this Note is registered on the records of the Company regarding registration and transfers of Notes in cash or converted into share of common stock of the Company (“Common Stock”) at the Conversion Price provided the Equity Conditions are satisfied.

 

    1

     

    

 

 (c)           Security. This Note shall not be secured by any collateral or any assets pledged to the Holder

 

 (d)          Moratorium on Variable Securities. For a period of 90 (ninety) days following the issuance date, the Company shall not at any time make any Variable Security Issuances (as defined below) to anyone other than Investor without Investor’s prior written consent, which consent may be granted or withheld in Investor’s sole and absolute discretion. “Variable Security Issuance” shall mean any issuance of any security that (i) has or may have conversion rights of any kind, contingent, conditional or otherwise, in which the number of shares that may be issued pursuant to such conversion right varies with the market price of the Common Stock, or (ii) is or may become convertible into Common Stock (including without limitation convertible debt, debentures, warrants or convertible preferred stock), with a conversion price that varies with the market price of the Common Stock, even if such security only becomes convertible following an event of default, the passage of time, or another trigger event or condition. For avoidance of doubt, the issuance of shares of Common Stock under, pursuant to, in exchange for or in connection with any contract or instrument, whether convertible or not, is deemed a Variable Security Issuance for purposes hereof if the number of shares of Common Stock to be issued is based upon or related in any way to the market price of the Common Stock, including, but not limited to, Common Stock issued in connection with a Section 3(a)(9) exchange, a Section 3(a)(10) settlement, or any other similar settlement or exchange.

 

		(2)	EVENTS OF DEFAULT.

 

 (a)           An “Event of Default”, wherever used herein, means any one of the following events (whatever the reason and whether it shall be voluntary or involuntary or effected by operation of law or pursuant to any judgment, decree or order of any court, or any order, rule or regulation of any administrative or governmental body):

 

 

 (i)      The Company's failure to pay to the Holder any amount of Principal, Interest, or other amounts when and as due under this Note (including, without limitation, the Company's failure to pay any redemption payments or amounts hereunder);

 

 (ii)      A Conversion Failure as defined in section 3(b)(ii)

 

 (iii)    The Company or any subsidiary of the Company shall commence,

 

or
there shall be commenced against the Company or any subsidiary of the Company under any applicable bankruptcy or insolvency
laws as now or hereafter in effect or any successor thereto, or the Company or any subsidiary of the Company commences any
other proceeding under any reorganization, arrangement, adjustment of debt, relief of debtors, dissolution, insolvency or
liquidation or similar law of any jurisdiction whether now or hereafter in effect relating to the Company or any subsidiary
of the Company or there is commenced against the Company or any subsidiary of the Company any such bankruptcy, insolvency or
other proceeding which remains undismissed for a period of 61 days; or the Company or any subsidiary of the Company is
adjudicated insolvent or bankrupt; or any order of relief or other order approving any such case or proceeding is entered; or
the Company or any subsidiary of the Company suffers any appointment of any custodian, private or court appointed receiver or
the like for it or any substantial part of its property which continues undischarged or unstayed for a period of sixty one
(61) days; or the Company or any subsidiary of the Company makes a general assignment for the benefit of creditors; or the
Company or any subsidiary of the Company shall fail to pay, or shall state that it is unable to pay, or shall be unable to
pay, its debts generally as they become due; or the Company or any subsidiary of the Company shall call a meeting of its
creditors with a view to arranging a composition, adjustment or restructuring of its debts; or the Company or any subsidiary
of the Company shall by any act or failure to act expressly indicate its consent to, approval of or acquiescence in any of
the foregoing; or any corporate or other action is taken by the Company or any subsidiary of the Company for the purpose of
effecting any of the foregoing;

 

    2

     

    

 

(iv)    The
Company or any subsidiary of the Company shall default in any of its obligations under any other Note or any mortgage, credit
agreement or other facility, indenture agreement, factoring agreement or other instrument under which there may be issued, or
by which there may be secured or evidenced any indebtedness for borrowed money or money due under any long term leasing or
factoring arrangement of the Company or any subsidiary of the Company in an amount exceeding $100,000, whether such
indebtedness now exists or shall hereafter be created; and

 

 (v)     The Common Stock is suspended or delisted for trading on the Over the Counter OTCQB Venture Marketplace or OTCPink Open Marketplace (the “Primary Market”).

 

 (vi) The Company loses its ability to deliver shares via “DWAC/FAST” electronic transfer.

 

 (vii)    The Company loses its status as “DTC Eligible.”

 

 (viii) The Company shall become late or delinquent in its filing requirements as a fully-reporting issuer registered with the Securities & Exchange Commission.

 

 (ix)     The Company shall fail to reserve and keep available out of its authorized Common Stock a number of shares equal to at least 5 (five) times the full number of shares of Common Stock issuable upon conversion of all outstanding amounts under this Note.

 

 (x)     The Company shall fail to meet all requirements to satisfy the availability of Rule 144 to the Holder or its assigns including but not limited to timely fulfillment of its filing requirements as a fully-reporting issuer registered with the SEC, requirements for XBRL filings, and requirements for disclosure of financial statements on its website.

 

 (xi)     Failure to comply with Section 1(d) of this Note.

 

    3

     

    

 

 (xii)    Failure to register shares as per section 1.4 of the Securities Purchase Agreement, attached hereto as Exhibit C.

 

		(b)	Upon the occurrence of any Event of Default (without the need for any party to give any notice or take any other action), the
Outstanding Balance shall immediately and automatically increase to 120% of the Outstanding Balance immediately prior to the occurrence
of the Event of Default (the “Default Sum”). Upon the occurrence of any Event of Default, the Note shall become immediately
due and payable and the Borrower shall pay to the Holder, in full satisfaction of its obligations hereunder, an amount equal to
the Outstanding Balance, all without demand, presentment or notice, all of which hereby are expressly waived, together with all
costs, including, without limitation, legal fees and expenses, of collection, and the Holder shall be entitled to exercise all
other rights and remedies available at law or in equity.

 

 (3) CONVERSION OF NOTE. This Note shall be convertible into shares of the Company's Common Stock, on the terms and conditions set forth in this Section 3.

 

(a)           Conversion
Right. Subject to the provisions of Section 3(c), at any time or times on or after the Issuance Date, the Holder
shall be entitled to convert any portion of the outstanding and unpaid Conversion Amount (as defined below) into fully paid
and nonassessable shares of Common Stock in accordance with Section 3(b), at the Conversion Price (as defined below).
The number of shares of Common Stock issuable upon conversion of any Conversion Amount pursuant to this
Section 3(a) shall be equal to the quotient of dividing the Conversion Amount by the Conversion Price. The Company
shall not issue any fraction of a share of Common Stock upon any conversion. If the issuance would result in the issuance of
a fraction of a share of Common Stock, the Company shall round such fraction of a share of Common Stock up to the nearest
whole share. The Company shall pay any and all transfer agent fees, legal fees, costs and any other fees or costs that may be
incurred or charged in connection with the issuance of shares of the Company’s Common Stock to the Holder arising out
of or relating to the conversion of this Note.

 

(i)       "Conversion
Amount" means the portion of the Original Principal Amount and Interest to be converted, plus any penalties, redeemed
or otherwise with respect to which this determination is being made.

 

(ii)      "Conversion
Price" shall equal $0.35 per share.

 

		(b)	Mechanics of Conversion.

 

(i)       Optional
Conversion. To convert any Conversion Amount into

 

shares of Common Stock on any
date (a "Conversion Date"), the Holder shall (A) transmit by email, facsimile (or otherwise deliver), for
receipt on or prior to 11:59 p.m., New York, NY Time, on such date, a copy of an executed notice of conversion in the form attached
hereto as Exhibit A (the "Conversion Notice") to the Company. On or before the third Business Day
following the date of receipt of a Conversion Notice (the "Share Delivery Date"), the Company shall (A) if
legends are not required to be placed on certificates of Common Stock pursuant to the then existing provisions of Rule 144
of the Securities Act of 1933 (“Rule 144”) and provided that the Transfer Agent is participating in the Depository
Trust Company's ("DTC") Fast Automated Securities Transfer Program, credit such aggregate number of shares of
Common Stock to which the Holder shall be entitled to the Holder's or its designee's balance account with DTC through its Deposit
Withdrawal Agent Commission system or (B) if the Transfer Agent is not participating in the DTC Fast Automated Securities
Transfer Program, issue and deliver to the address as specified in the Conversion Notice, a certificate, registered in the name
of the Holder or its designee, for the number of shares of Common Stock to which the Holder shall be entitled which certificates
shall not bear any restrictive legends unless required pursuant the Rule 144. If this Note is physically surrendered for conversion
and the outstanding Principal of this Note is greater than the Principal portion of the Conversion Amount being converted, then
the Company shall, upon request of the Holder, as soon as practicable and in no event later than three (3) Business Days after
receipt of this Note and at its own expense, issue and deliver to the holder a new Note representing the outstanding Principal
not converted. The Person or Persons entitled to receive the shares of Common Stock issuable upon a conversion of this Note shall
be treated for all purposes as the record holder or holders of such shares of Common Stock upon the transmission of a Conversion
Notice.

 

    4

     

    

 

(ii)      Company's
Failure to Timely Convert. If within two (2) Trading Days after the Company's receipt of the facsimile or email copy of
a Conversion Notice the Company shall fail to issue and deliver to Holder via “DWAC/FAST” electronic transfer the number
of shares of Common Stock to which the Holder is entitled upon such holder's conversion of any Conversion Amount (a "Conversion
Failure"), the Original Principal Amount of the Note shall increase by $2,000 per day until the Company issues and delivers
a certificate to the Holder or credit the Holder's balance account with DTC for the number of shares of Common Stock to which the
Holder is entitled upon such holder's conversion of any Conversion Amount (under Holder’s and Company’s expectation
that any damages will tack back to the Issuance Date). Company will not be subject to any penalties once its transfer agent
processes the shares to the DWAC system. If the Company fails to deliver shares in accordance with the timeframe stated in
this Section, resulting in a Conversion Failure, the Holder, at any time prior to selling all of those shares, may rescind any
portion, in whole or in part, of that particular conversion attributable to the unsold shares and have the rescinded conversion
amount returned to the Outstanding Balance with the rescinded conversion shares returned to the Company (under Holder’s and
Company’s expectations that any returned conversion amounts will tack back to the original date of the Note).

 

(iii)     DWAC/FAST
Eligibility. If the Company fails for any reason to deliver to the Holder the Shares by DWAC/FAST
electronic transfer (such as by delivering a physical stock certificate), or if there is a Conversion Failure as defined in Section 3(b)(ii),
and if the Holder incurs a Market Price Loss, then at any time subsequent to incurring the loss the Holder may provide the Company
written notice indicating the amounts payable to the Holder in respect of the Market Price Loss and the Company must make the
Holder whole by either of the following options at Holder’s election: Market Price Loss = [(High trade price for the period
between the day of conversion and the day the shares clear in the Holder’s brokerage account) x (Number of shares receivable
from the conversion)] – [(Net Sales price realized by Holder) x (Number of shares receivable from the conversion)].

 

    5

     

    

 

Option
A – Pay Market Price Loss in Cash. The Company must pay the Market Price Loss by cash payment, and any such cash payment
must be made by the third business day from the time of the Holder’s written notice to the Company.

 

Option
B – Add Market Price Loss to Outstanding Balance. The Company must pay the Market Price Loss by adding the Market Price Loss
to the Outstanding Balance (under Holder’s and the Company’s expectation that any Market Price Loss amounts will tack
back to the Issuance Date).

 

In the
case that conversion shares are not deliverable by DWAC/FAST electronic transfer an additional 10% discount to the Conversion Price
will apply.

 

(iv)    DTC
Eligibility & Sub-Penny. If the Company fails to maintain its status as “DTC Eligible” for any
reason, or, if the effective Conversion Price as calculated in Section 3(a)(ii) is less than $0.01 at any time
(regardless of whether or not a Conversion Notice has been submitted to the Company), the Principal Amount of the Note shall
increase by ten thousand dollars ($10,000) (under Holder’s and Company’s expectation that any Principal Amount
increase will tack back to the Issuance Date). In addition, the Conversion Price shall be permanently redefined to equal the
lesser of (a) $0.01 or (b) 50% of the lowest trade occurring during the twenty five (25) consecutive Trading Days
immediately preceding the applicable Conversion Date on which the Holder elects to convert all or part of this Note, subject
to adjustment as provided in this Note.

 

(v)     Default
Conversion Price. Upon the occurrence of any Event of Default (without the need for any party to give any notice or take any
other action), the Conversion Price shall be redefined to equal the Default Conversion Price. The Default conversion price shall
be defined as 60% of the lowest trade occurring during the twenty five (25) consecutive Trading Days immediately preceding the
applicable Conversion Date on which the Holder elects to convert all or part of this Note, subject to adjustment as provided in
this Note.

 

(vi)     Par
Value True-Up. In the event that the Conversion Price is less than Par Value on the Conversion Date, the Holder may elect
to submit a Conversion Notice (attached hereto as Exhibit A) with a conversion price equal to the Company’s Par
Value. In addition, upon written notice from the Holder in the form attached hereto as Exhibit B (the
 “True-Up Notice”), the Holder may require the Company, at the Holder’s election, to either (A) issue
and deliver to the Holder a number of shares of Common Stock as equals (X) the Conversion Amount divided by 60% of the
lowest trade occurring during the twenty five (25) consecutive Trading Days immediately preceding the applicable Conversion
Date, less (Y) the Conversion Amount divided by the Par Value (Any additional shares of Common Stock issuable pursuant
to this Section 3(b)(v) shall be referred to herein as “True-Up Shares”), or (B) add to the
Outstanding Balance a dollar amount equal to the number of True-Up Shares (as calculated above) multiplied by the high trade
price on the Conversion Date (Any dollar amount added to the Outstanding Balance pursuant to this
Section 3(b)(v) shall be referred to herein as the “True-Up Balance”) (under Holder’s and the
Company’s expectation that any True-Up Balance amounts will tack back to the Issuance Date).

 

(vii)    Book-Entry.
Notwithstanding anything to the contrary set forth herein, upon conversion of any portion of this Note in accordance with the
terms hereof, the Holder shall not be required to physically surrender this Note to the Company unless (A) the full
Conversion Amount represented by this Note is being converted or (B) the Holder has provided the Company with prior
written notice (which notice may be included in a Conversion Notice) requesting reissuance of this Note upon physical
surrender of this Note. The Holder and the Company shall maintain records showing the Principal and Interest converted and
the dates of such conversions or shall use such other method, reasonably satisfactory to the Holder and the Company, so as
not to require physical surrender of this Note upon conversion.

 

    6

     

    

 

		(c)	Limitations on Conversions or Trading.

 

 

(i)       Beneficial
Ownership. The Company shall not effect any conversions of this Note and the Holder shall not have the right to convert
any portion of this Note or receive shares of Common Stock as payment of interest hereunder to the extent that after giving
effect to such conversion or receipt of such interest payment, the Holder, together with any affiliate thereof, would
beneficially own (as determined in accordance with Section 13(d) of the Exchange Act and the rules promulgated
thereunder) in excess of 4.99% of the number of shares of Common Stock outstanding immediately after giving effect to such
conversion or receipt of shares as payment of interest. Since the Holder will not be obligated to report to the Company the
number of shares of Common Stock it may hold at the time of a conversion hereunder, unless the conversion at issue would
result in the issuance of shares of Common Stock in excess of 4.99% of the then outstanding shares of Common Stock without
regard to any other shares which may be beneficially owned by the Holder or an affiliate thereof, the Holder shall have the
authority and obligation to determine whether the restriction contained in this Section will limit any particular
conversion hereunder and to the extent that the Holder determines that the limitation contained in this Section applies,
the determination of which portion of the principal amount of this Note is convertible shall be the responsibility and
obligation of the Holder. If the Holder has delivered a Conversion Notice for a principal amount of this Note that, without
regard to any other shares that the Holder or its affiliates may beneficially own, would result in the issuance in excess of
the permitted amount hereunder, the Company shall notify the Holder of this fact and shall honor the conversion for the
maximum principal amount permitted to be converted on such Conversion Date in accordance with Section 3(a) and, any
principal amount tendered for conversion in excess of the permitted amount hereunder shall remain outstanding under this
Note. In the event that the Market Capitalization of the Company falls below $2,500,000, the term “4.99%” above
shall be permanently replaced with “9.99%”. “Market Capitalization” shall be defined as the product
of (a) the closing price of the Common Stock of the Common stock multiplied by (b) the number of shares of Common
Stock outstanding as reported on the Company’s most recently filed Form 10-K or Form 10-Q. The provisions of
this Section may be waived by Holder upon not less than 65 days prior written notification to the Company.

 

(ii)      Capitalization.
So long as this as this Note is outstanding, upon written request of the Holder, the Company shall furnish to the Holder the
then-current number of common shares issued and outstanding, the then-current number of common shares authorized, and the
then-current number of shares reserved for third parties.

 

		(d)	Other Provisions.

 

(i)            Share
Reservation.    The Company shall at all times reserve and keep available out of its authorized Common
Stock a number of shares equal to at least 5 (five) times the full number of shares of Common Stock issuable upon conversion
of all outstanding amounts under this Note; and within 3 (three) Business Days following the receipt by the Company of a
Holder's notice that such minimum number of shares of Common Stock is not so reserved, the Company shall promptly reserve a
sufficient number of shares of Common Stock to comply with such requirement. The Company will at all times reserve at least
5,000,000 shares of Common Stock for conversion.

 

(ii)            Prepayment.
     At any time within the 90 day period immediately following the Issuance Date, the Company shall have
the option, upon 10 business days’ notice to Holder, to pre-pay the entire remaining outstanding principal amount of
this Note in cash, provided that (i) the Company shall pay the Holder 130% of the Outstanding Balance, (ii) such
amount must be paid in cash on the next business day following such 10 business day notice period, and (iii) the Holder
may still convert this Note pursuant to the terms hereof at all times until such prepayment amount has been received in full.
Except as set forth in this Section the Company may not prepay this Note in whole or in part.

 

    7

     

    

 

(iii)             Terms of Future Issuances. So long as this Note is outstanding, upon any issuance by the
Company or any of its subsidiaries of any promissory note, debenture or security (each referred to as a
 “Security”) (or upon any amendment to or conversion of any existing Security) with any term more favorable to the
holder of such Security or with a term in favor of the holder of such Security that was not similarly provided to the Holder
in this Note, then the Company shall notify the Holder of such additional or more favorable term and such term, at
Holder’s option, shall become a part of the Note. The types of terms contained in another Security that may be more
favorable to the holder of such Security include, but are not limited to, terms addressing conversion discounts, conversion
lookback periods, conversions or exchanges of existing notes or debentures, interest rates, original issue discounts, stock
sale price, private placement price per share, and warrant coverage.

 

(iv)     Dilutive
Issuances. If the Company or any Subsidiary thereof, as applicable, at any time while this Note is outstanding, shall
sell or grant any option to purchase, or sell or grant any right to re-price, or otherwise dispose of or issue (or announce
any offer, sale, grant or any option to purchase or other disposition) any Common Stock or Common Stock Equivalents entitling
any Person to acquire shares of Common Stock, at an effective price per share less than the then Conversion Price (such lower
price, the “Base Share Price” and such issuances collectively, a “Dilutive Issuance”) (if the holder
of the Common Stock or Common Stock Equivalents so issued shall at any time, whether by operation of purchase price
adjustments, reset provisions, floating conversion, exercise or exchange prices or otherwise, or due to warrants, options or
rights per share which are issued in connection with such issuance, be entitled to receive shares of Common Stock at an
effective price per share which is less than the Conversion Price, such issuance shall be deemed to have occurred for less
than the Conversion Price on such date of the Dilutive Issuance), then the Conversion Price shall be reduced and only reduced
to equal the Base Share Price. Such adjustment shall be made whenever such Common Stock or Common Stock Equivalents are
issued. The Company shall notify the Holder in writing, no later than the Trading Day following the issuance of any Common
Stock or Common Stock Equivalents subject to this Section 3(d)(iv), indicating therein the applicable issuance price, or
applicable reset price, exchange price, conversion price and other pricing terms (such notice the “Dilutive Issuance
Notice”). For purposes of clarification, whether or not the Company provides a Dilutive Issuance Notice pursuant to
this Section 3(d)(iv), upon the occurrence of any Dilutive Issuance, after the date of such Dilutive Issuance the Holder
is entitled to receive a number of shares based upon the Base Share Price regardless of whether the Holder accurately refers
to the Base Share Price in the Conversion Notice.

 

(v)     
All calculations under this Section 3 shall be rounded up to the nearest $0.00001 or whole share.

 

(vi)    
Nothing herein shall limit a Holder's right to pursue actual damages or declare an Event of Default pursuant to
Section 2 herein for the Company's failure to deliver certificates representing shares of Common Stock upon conversion
within the period specified herein and such Holder shall have the right to pursue all remedies available to it at law or in
equity including, without limitation, a decree of specific performance and/or injunctive relief, in each case without the
need to post a bond or provide other security. The exercise of any such rights shall not prohibit the Holder from seeking to
enforce damages pursuant to any other Section hereof or under applicable law.

 

    8

     

    

 

(4)      SECTION 3(A)(9) OR
3(A)(10) TRANSACTION. So long as this Note is outstanding, the Company shall not enter into any transaction or
arrangement structured in accordance with, based upon, or related or pursuant to, in whole or in part, either
Section 3(a)(9) of the Securities Act (a “3(a)(9) Transaction”) or Section 3(a)(10) of
the Securities Act (a “3(a)(10) Transaction”). In the event that the Company does enter into, or makes any
issuance of Common Stock related to a 3(a)(9) Transaction or a 3(a)(10) Transaction while this note is outstanding,
a liquidated damages charge of 25% of the outstanding principal balance of this Note, but not less than $25,000, will be
assessed and will become immediately due and payable to the Holder at its election in the form of cash payment or addition to
the balance of this Note.

 

(5)      PIGGYBACK
REGISTRATION RIGHTS. The Company shall include on the next registration statement the Company files with SEC (or on the
subsequent registration statement if such registration statement is withdrawn) all shares issuable upon conversion of this
Note. Failure to do so will result in liquidated damages of 25% of the outstanding principal balance of this Note, but not
less than $25,000, being immediately due and payable to the Holder at its election in the form of cash payment or addition to
the balance of this Note.

 

		(6)	REISSUANCE OF THIS NOTE.

 

		(a)	Assignability. The Company may not assign this Note. This Note will be binding upon the Company and its successors and
will inure to the benefit of the Holder and its successors and assigns and may be assigned by the Holder to anyone of its choosing
without Company’s approval.

 

		(b)	Lost, Stolen or Mutilated Note. Upon receipt by the Company of evidence reasonably satisfactory to the Company of the
loss, theft, destruction or mutilation of this Note, and, in the case of loss, theft or destruction, of any indemnification undertaking
by the Holder to the Company in customary form and, in the case of mutilation, upon surrender and cancellation of this
Note, the Company shall execute and deliver to the Holder a new Note representing the outstanding Principal.

 

(7)           NOTICES.
Any notices, consents, waivers or other communications required or permitted to be given under the terms hereof must be in
writing and will be deemed to have been delivered: (i) upon receipt, when delivered personally; (ii) upon receipt,
when sent by facsimile (provided confirmation of transmission is mechanically or electronically generated and kept on file by
the sending party) (iii) upon receipt, when sent by email; or (iv) one (1) Trading Day after deposit with a
nationally recognized overnight delivery service, in each case properly addressed to the party to receive the same. The
addresses and facsimile numbers for such communications shall be those set forth in the communications and documents that
each party has provided the other immediately preceding the issuance of this Note or at such other address and/or facsimile
number and/or to the attention of such other person as the recipient party has specified by written notice given to each
other party three (3) Business Days prior to the effectiveness of such change. Written confirmation of receipt
(i) given by the recipient of such notice, consent, waiver or other communication, (ii) mechanically or
electronically generated by the sender's facsimile machine containing the time, date, recipient facsimile number and an image
of the first page of such transmission or (iii) provided by a nationally recognized overnight delivery service,
shall be rebuttable evidence of personal service, receipt by facsimile or receipt from a nationally recognized overnight
delivery service in accordance with clause (i), (ii) or (iii) above, respectively.

 

    9

     

    

 

The addresses for such communications
shall be:

 

If to the Company, to:

 

Electromedical Technologies, Inc.

16561 N 92nd St., Suite 101

Scottsdale AZ 85260

Attn: Matthew Wolfson

Email: ceo@electromedtech.com

 

If to the Holder:

 

VISTA CAPITAL INVESTMENTS,
LLC

120 Birmingham Drive, Suite 230

Cardiff by the Sea CA 92007

Attn:     David Clark, Managing
Member

Email: dclark@vci.us.com

 

(8)            APPLICABLE
LAW AND VENUE. This Note shall be governed by and construed in accordance with the laws of the State of Nevada, without giving
effect to conflicts of laws thereof. Any action brought by either party against the other concerning the transactions contemplated
by this Agreement shall be brought only in the state courts of California or in the federal courts located in the city and county
of San Diego, in the State of California. Both parties and the individuals signing this Agreement agree to submit to the jurisdiction
of such courts.

 

(9)            WAIVER.
Any waiver by the Holder of a breach of any provision of this Note shall not operate as or be construed to be a waiver of any other
breach of such provision or of any breach of any other provision of this Note. The failure of the Holder to insist upon strict
adherence to any term of this Note on one or more occasions shall not be considered a waiver or deprive that party of the right
thereafter to insist upon strict adherence to that term or any other term of this Note. Any waiver must be in writing.

 

(10)            LIQUIDATED
DAMAGES. Holder and Company agree that in the event Company fails to comply with any of the terms or provisions of this Note,
Holder's damages would be uncertain and difficult (if not impossible) to accurately estimate because of the parties' inability
to predict future interest rates, future share prices, future trading volumes and other relevant factors. Accordingly, Holder and
Company agree that any fees, balance adjustments, default interest or other charges assessed under this Note are not penalties
but instead are intended by the parties to be, and shall be deemed, liquidated damages (under Holder's and Company's expectations
that any such liquidated damages will tack back to the Closing Date for purposes of determining the holding period under Rule 144).

 

(11)            ADJUSTMENTS.
Notwithstanding anything to the contrary, any references herein to share numbers or share prices shall be appropriately adjusted
for any stock dividend, stock split, stock combination or other similar transaction during such period.

 

[Signature Page Follows]

 

    10

     

    

 

IN WITNESS WHEREOF,
the Company has caused this Convertible Note to be duly executed by a duly authorized officer as of the date set forth above.

 

	 	COMPANY:
	 	 
	 	Electromedical
    Technologies, Inc.
	 	 
	 	By:	
	 	 
	 	Name:
    Matthew Wolfson
	 	 
	 	Title:     Chief
    Executive Officer
	 	 
	 	HOLDER:
	 	 
	 	VISTA
    CAPITAL INVESTMENTS, LLC.
	 	 
	 	By:	 
	 	 
	 	Name:
    David Clark
	 	 
	 	Title:
    Managing Member

 

[Signature Page to Convertible Note
No. ELCQ-1]

 

    

     

    

 

EXHIBIT A
CONVERSION NOTICE

 

	[Company Contact, Position]	Electromedical Technologies, Inc.

 

[Company Address]

 

[Contact Email Address}

 

The undersigned hereby elects
to convert a portion of the $________ Convertible Note _______ issued to Vista Capital Investments, LLC on ____________ into Shares
of Common Stock of ____________ according to the conditions set forth in such Note as of the date written below.

 

By accepting this notice of
conversion, you are acknowledging that the number of shares to be delivered represents less than 10% (ten percent) of the common
stock outstanding. If the number of shares to be delivered represents more than 9.99% of the common stock outstanding, this conversion
notice shall immediately automatically extinguish and debenture Holder must be immediately notified.

 

	Date of Conversion:	 	 
	 	 	 
	 	 	 
	 	 	 
	 	 	 

 

Conversion Amount:

 

Conversion Price:

 

Shares to be Delivered:

 

Shares delivered in name of:

 

VISTA CAPITAL INVESTMENTS, LLC

 

	Signature:	 
	 	By:
	 	Title:
	 	 
	 	Vista Capital Investments, LLC

 

    

     

    

 

EXHIBIT B
TRUE-UP NOTICE

 

[Company
Contact, Position]

 

Electromedical Technologies, Inc.

 

[Company Address]

 

[Contact
Email Address}

 

The
undersigned hereby gives notice to Electromedical Technologies, Inc., a ______ corporation (the
 “Company”), pursuant to that certain Note dated _______ ___, 20__ by and between the Company and the Holder (the
 “Note”), that the Holder elects to:

 

___ Receive
fully paid and non-assessable True-Up Shares pursuant to Section 3(b)(v) of the Note (such Additional Origination Shares
shall be calculated as set forth below), or

 

___ Add
to the Outstanding Balance a dollar amount equal to the True-Up Amount (such True-Up Amount shall be calculated as set forth below).

 

The number
of True-Up Shares Holder is entitled to receive is calculated as follows:

 

Conversion
Amount ($___) / ___% of the lowest trade occurring during the _________ (__) consecutive Trading Days immediately preceding the
applicable Conversion Date ($_.__) - Conversion Amount ($___) divided by the Par Value ($_.__) =

 

____________ True-Up
Shares

 

The amount
of True-Up Balance to be added to the Outstanding Balance is calculated as follows:

 

Number
of True-Up Shares (_____) * high trade price on the Conversion Date ($_.__)=

 

____________ True-Up
Balance

 

Shares delivered in name of:

 

VISTA CAPITAL INVESTMENTS,
LLC

 

	Signature:	 
	 	By:
	 	Title:
	 	 
	 	Vista Capital Investments, LLC

 

    

     

    

 

EXHIBIT C

 

SECURITIES PURCHASE AGREEMENTExhibit 10.37

 

THIS WARRANT
AND THE COMMON STOCK ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED.
THIS WARRANT AND THE COMMON STOCK ISSUABLE UPON EXERCISE OF THIS WARRANT MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED
IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT AS TO THIS WARRANT UNDER SUCH ACT AND ANY APPLICABLE STATE SECURITIES LAW
OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO ELECTROMEDICAL TECHNOLOGIES, INC. THAT SUCH REGISTRATION IS NOT REQUIRED.

 

ELECTROMEDICAL TECHNOLOGIES, INC.

 

WARRANT TO PURCHASE SHARES OF COMMON STOCK

 

                1.             Issuance.
In consideration of good and valuable consideration as set forth in the Purchase Agreement (defined below), including without
limitation the Purchase Price (as defined in the Purchase Agreement), the receipt and sufficiency of which are hereby
acknowledged by ELECTROMEDICAL TECHNOLOGIES, INC.,
a Colorado corporation (the “Company”); VISTA CAPITAL INVESTMENTS,
LLC, its successors and/or registered assigns (the “Holder”), is hereby granted the right to purchase at
any time on or after the Issue Date (as defined below) until the date which is the last calendar day of the month in which
the third anniversary of the Issue Date occurs (the “Expiration Date”), 250,000 fully paid and
nonassessable shares (the “Warrant Shares”) of the Company’s common stock, par value $0.001 per
share (the “Common Stock”), as such number of Warrant Shares may be adjusted from time to time pursuant to
the terms and conditions of this Warrant to Purchase Shares of Common Stock (this “Warrant”). This Warrant
is being issued pursuant to the terms of that certain Securities Purchase Agreement dated June 4, 2020, to which the
Company and the Holder are parties (as the same may be amended from time to time, the “Purchase
Agreement”).

 

Unless otherwise indicated
herein, capitalized terms not otherwise defined herein shall have the meanings ascribed to them in the Purchase Agreement.

 

This Warrant was originally issued to the
Holder on June 4, 2020 (the “Issue Date”).

 

		2.	Exercise of Warrant.

 

2.1.            General.

 

(a)            This
Warrant is exercisable in whole or in part at any time and from time to time commencing on the Issue Date and ending on the
Expiration Date. Such exercise shall be effectuated by submitting to the Company (either by delivery to the Company or by
email or facsimile transmission) a completed and duly executed Notice of Exercise substantially in the form attached to this
Warrant as Exhibit A (the “Notice of Exercise”). The date such Notice of Exercise is either
faxed, emailed or delivered to the Company shall be the “Exercise Date,” provided that, if such exercise
represents the full exercise of the outstanding balance of the Warrant, the Holder shall tender this Warrant to the Company
within five (5) Trading Days thereafter, but only if the Warrant Shares to be delivered pursuant to the Notice of
Exercise have been delivered to the Holder as of such date. The Notice of Exercise shall be executed by the Holder and shall
indicate (i) the number of Warrant Shares (as defined below) to be issued pursuant to such exercise, and (ii) if
applicable (as provided below), whether the exercise is a cashless exercise.

 

    1

     

    

 

For purposes of
this Warrant, the term “Trading Day” means any day during which the principal market on which the Common
Stock is traded (the “Principal Market”) shall be open for business. (b)  To the extent this Warrant
is not previously exercised, and if the Market Price of one Warrant Share is greater than the Exercise Price, the Holder may
elect to receive Warrant Shares, in lieu of a cash exercise, equal to the value of this Warrant determined in the manner
described below (or of any portion thereof remaining unexercised) by surrender of this Warrant and a Notice of Exercise, in
which event the Company shall issue to Holder a number of Shares computed using the following formula:

 

		X	= Y (A-B)

 

A

 

	Where X	=	the number of Warrant Shares to be issued to Holder.

 

	Y	=	the number of Warrant Shares that the Holder elects to purchase under this Warrant (at the date of such calculation).

 

		A	=	the Market Price (at the date of such calculation).

 

		B	=	Exercise Price (as adjusted to the date of such calculation).

 

For the
purposes of this Warrant, the following terms shall have the following meanings:

 

“Affiliate”
shall mean an affiliate as such term is defined in Rule 144 under the Securities Act of 1933, as amended (or a successor rule).

 

“Aggregate
Exercise Price Payable” shall mean the product of multiplying the number of Warrant Shares exercisable by the Exercise
Price.

 

“Closing Price”
shall mean the 4:00 P.M. last sale price of the Common Stock on the Principal Market on the relevant Trading Day(s), as reported
by Bloomberg LP (or if that service is not then reporting the relevant information regarding the Common Stock, a comparable reporting
service of national reputation selected by the Holder and reasonably acceptable to the Company) (“Bloomberg”)
for the relevant date.

 

“Deemed Issuance”
means a requested conversion under the Note that is not honored by the Company.

 

“Exercise
Price” shall mean $1.00 per share of Common Stock, subject to adjustments herein.

 

“Market Price”
shall mean the Closing Price for the Common Stock on the Trading Day that is two Trading Days prior to the Exercise Date.

 

“Note”
shall mean that certain Convertible Promissory Note issued by the Company to the Holder pursuant to the Purchase Agreement, as
the same may be amended from time to time, and including any promissory note(s) that replace or are exchanged for such referenced
promissory note.

 

    2

     

    

 

(c)            If
the Notice of Exercise form elects a “cash” exercise (or if the cashless exercise referred to in the immediately
preceding subsection (b) is not available in accordance with the terms hereof), the Exercise Price per share of Common
Stock for the Warrant Shares shall be payable, at the election of the Holder, in cash or by certified or official bank check
or by wire transfer in accordance with instructions provided by the Company at the request of the Holder.

 

(d)            Upon
the appropriate payment to the Company, if any, of the Exercise Price for the Warrant Shares, together with the surrender of
this Warrant (if required), the Company shall promptly, but in no case later than the date that is three (3) Trading
Days following the date the Exercise Price is paid to the Company (or with respect to a “cashless exercise,” the
date that is three (3) Trading Days following the Exercise Date) (the “Delivery Date”), provided that
all DWAC Eligible Conditions (as defined in the Note) are then satisfied, deliver or cause the Company’s Transfer Agent
to deliver the applicable Warrant Shares electronically via the Deposit/Withdrawal at Custodian (“DWAC”)
system to the account designated by the Holder on the Notice of Exercise. If all DWAC Eligible Conditions are not then
satisfied, the Company shall instead issue and deliver or cause to be issued and delivered (via reputable overnight courier)
to the address as specified in the Notice of Exercise, a certificate, registered in the name of the Holder or its designee,
for the number of Warrant Shares to which the Holder shall be entitled. For the avoidance of doubt, the Company has not met
its obligation to deliver Warrant Shares by the Delivery Date unless the Transfer Agent has posted the shares for DWAC pickup
and the Holder or its broker, as applicable, has been notified of this availability, or if the DWAC Eligible Conditions are
not then satisfied, has actually received the certificate representing the applicable Warrant Shares no later than the close
of business on the relevant Delivery Date pursuant to the terms set forth above.

 

(e)            If
Warrant Shares are delivered later than as required under subsection (d) immediately above, the Company agrees to pay, in
addition to all other remedies available to the Holder in the Transaction Documents, a late charge equal to the greater of (i) $2,000.00
and (ii) 2% of the product of (1) the sum of the number of shares of Common Stock not issued to the Holder on a timely
basis and to which the Holder is entitled multiplied by (2) the Closing Price of the Common Stock on the Trading Day immediately
preceding the last possible date which the Company could have issued such shares of Common Stock to the Holder without violating
this Warrant, per Trading Day until such Warrant Shares are delivered. The Company shall pay any late charges incurred under this
subsection in immediately available funds upon demand; provided, however, that, at the option of the Holder (without notice
to the Company), such amount owed may be added to the principal amount of the Note. Furthermore, in addition to any other remedies
which may be available to the Holder, in the event that the Company fails for any reason to effect delivery of the Warrant Shares
as required under subsection (d) immediately above, the Holder may revoke all or part of the relevant Warrant exercise by
delivery of a notice to such effect to the Company, whereupon the Company and the Holder shall each be restored to their respective
positions immediately prior to the exercise of the relevant portion of this Warrant, except that the late charge described above
shall be payable through the date notice of revocation or rescission is given to the Company.

 

(f)            The
Holder shall be deemed to be the holder of the Warrant Shares issuable to it in accordance with the provisions of this Section 2.1
on the Exercise Date.

 

    3

     

    

 

2.2.            Ownership
Limitation. If at any time after the Closing, the Buyer shall or would receive shares of Common Stock in payment of
interest or principal under Note, upon conversion of Note, under the Warrant, or upon exercise of the Warrant, so that the
Buyer would, together with other shares of Common Stock held by it or its Affiliates, own or beneficially own by virtue of
such action or receipt of additional shares of Common Stock a number of shares exceeding 9.99% of the number of shares of
Common Stock outstanding on such date (the “Maximum Percentage”), the Company shall not be obligated and
shall not issue to the Buyer shares of Common Stock which would exceed the Maximum Percentage, but only until such time as
the Maximum Percentage would no longer be exceeded by any such receipt of shares of Common Stock by the Buyer. The foregoing
limitations are enforceable, unconditional and non-waivable and shall apply to all Affiliates and assigns of the Buyer.
Additionally, for so long as the Buyer or any of its Affiliate own Securities, upon written request from the Buyer, the
Company shall post (or cause to be posted), the then-current number of issued and outstanding shares of its capital stock to
the Company’s web page located at OTCmarkets.com (or such other web page approved by the Buyer).

 

3.            Mutilation
or Loss of Warrant. Upon receipt by the Company of evidence satisfactory to it of the loss, theft, destruction or mutilation
of this Warrant, and (in the case of loss, theft or destruction) receipt of reasonably satisfactory indemnification, and (in the
case of mutilation) upon surrender and cancellation of this Warrant, the Company will execute and deliver to the Holder a new Warrant
of like tenor and date and any such lost, stolen, destroyed or mutilated Warrant shall thereupon become void.

 

4.            Rights
of the Holder. The Holder shall not, by virtue of this Warrant alone, be entitled to any rights of a stockholder in the Company,
either at law or in equity, and the rights of the Holder with respect to or arising under this Warrant are limited to those expressed
in this Warrant and are not enforceable against the Company except to the extent set forth herein.

 

5.            Certain
Adjustments.

 

5.1.            Capital
Adjustments. If the Company shall at any time prior to the expiration of this Warrant subdivide the Common Stock, by
split-up or stock split, or otherwise, or combine its Common Stock, or issue additional shares of its Common Stock as a
dividend, the number of Warrant Shares issuable upon the exercise of this Warrant shall forthwith be automatically increased
proportionately in the case of a subdivision, split or stock dividend, or proportionately decreased in the case of a
combination. Appropriate adjustments shall also be made to the Exercise Price, Market Price (in the event of a cashless
exercise), and other applicable amounts, but the aggregate purchase price payable for the total number of Warrant Shares
purchasable under this Warrant (as adjusted) shall remain the same. Any adjustment under this Section 5.1 shall become
effective automatically at the close of business on the date the subdivision or combination becomes effective, or as of the
record date of such dividend, or in the event that no record date is fixed, upon the making of such dividend.

 

5.2.            Reclassification,
Reorganization and Consolidation. In case of any reclassification, capital reorganization, or change in the capital stock
of the Company (other than as a result of a subdivision, combination, or stock dividend provided for in Section 5.1
above), then the Company shall make appropriate provision so that the Holder shall have the right at any time prior to the
expiration of this Warrant to purchase, at a total price equal to that payable upon the exercise of this Warrant, the kind
and amount of shares of stock and other securities and property receivable in connection with such reclassification,
reorganization, or change by a holder of the same number of shares of Common Stock as were purchasable by the Holder
immediately prior to such reclassification, reorganization, or change. In any such case appropriate provisions shall be made
with respect to the rights and interest of the Holder so that the provisions hereof shall thereafter be applicable with
respect to any shares of stock or other securities and property deliverable upon exercise hereof, and appropriate adjustments
shall be made to the purchase price per Warrant Share payable hereunder, provided the aggregate purchase price shall remain
the same.

 

    4

     

    

 

5.3.            Dilutive
Issuances. If the Company or any Subsidiary thereof, as applicable, at any time while this Warrant is outstanding, shall
sell or grant any option to purchase, or sell or grant any right to re-price, or otherwise dispose of or issue (or announce
any offer, sale, grant or any option to purchase or other disposition) any Common Stock or Common Stock Equivalents entitling
any Person to acquire shares of Common Stock, at an effective price per share less than the then Exercise Price (such lower
price, the “Base Share Price” and such issuances collectively, a “Dilutive Issuance”)
(if the holder of the Common Stock or Common Stock Equivalents so issued shall at any time, whether by operation of purchase
price adjustments, reset provisions, floating conversion, exercise or exchange prices or otherwise, or due to warrants,
options or rights per share which are issued in connection with such issuance, be entitled to receive shares of Common Stock
at an effective price per share which is less than the Exercise Price, such issuance shall be deemed to have occurred for
less than the Exercise Price on such date of the Dilutive Issuance), then the Exercise Price shall be reduced and only
reduced to equal the Base Share Price and the number of Warrant Shares issuable hereunder shall be increased such that the
Aggregate Exercise Price Payable hereunder, after taking into account the decrease in the Exercise Price, shall be equal to
the Aggregate Exercise Price Prior to such adjustment. Such adjustment shall be made whenever such Common Stock or Common
Stock Equivalents are issued. The Company shall notify the Holder in writing, no later than the Trading Day following the
issuance of any Common Stock or Common Stock Equivalents subject to this Section 5.3, indicating therein the applicable
issuance price, or applicable reset price, exchange price, conversion price and other pricing terms (such notice the
 “Dilutive Issuance Notice”). For purposes of clarification, whether or not the Company provides a Dilutive
Issuance Notice pursuant to this Section 5.3, upon the occurrence of any Dilutive Issuance, after the date of such
Dilutive Issuance the Holder is entitled to receive a number of Warrant Shares based upon the Base Share Price regardless of
whether the Holder accurately refers to the Base Share Price in the Notice of Exercise. Notice of Adjustment. Without
limiting any other provision contained herein, when any adjustment is required to be made in the number or kind of shares
purchasable upon exercise of this Warrant, or in the Exercise Price, pursuant to the terms hereof, the Company shall promptly
notify the Holder of such event and of the number of Warrant Shares or other securities or property thereafter purchasable
upon exercise of this Warrant.

 

5.4.            [Reserved]

 

6.            Certificate
as to Adjustments. In each case of any adjustment or readjustment in the shares of Common Stock issuable on the exercise of
this Warrant, the Company at its expense will promptly cause its Chief Financial Officer or other appropriate designee to compute
such adjustment or readjustment in accordance with the terms of this Warrant and prepare a certificate setting forth such adjustment
or readjustment and showing in detail the facts upon which such adjustment or readjustment is based, including a statement of (a) the
consideration received or receivable by the Company for any additional shares of Common Stock issued or sold or deemed to have
been issued or sold, (b) the number of shares of Common Stock outstanding or deemed to be outstanding, and (c) the Exercise
Price and the number of shares of Common Stock to be received upon exercise of this Warrant, in effect immediately prior to such
adjustment or readjustment and as adjusted or readjusted as provided in this Warrant. The Company will forthwith mail a copy of
each such certificate to the Holder and any Warrant Agent (as defined below) appointed pursuant to Section 8 hereof. Nothing
in this Section 6 shall be deemed to limit any other provision contained herein.

 

    5

     

    

 

7.            Transfer
to Comply with the Securities Act. This Warrant, and the Warrant Shares, have not been registered under the 1933 Act.
This Warrant, the Warrant Shares and any other security issued or issuable upon exercise of this Warrant may only be sold,
transferred, pledged or hypothecated (other than to an Affiliate) if (a) there exists an effective registration
statement under the 1933 Act relating to such security or (b) the Company has received an opinion of counsel reasonably
satisfactory to the Company that registration is not required under the 1933 Act. Until such time as registration has
occurred under the 1933 Act, each certificate for this Warrant, the Warrant Shares and any other security issued or issuable
upon exercise of this Warrant shall contain a legend, in form and substance satisfactory to counsel for the Company, setting
forth the restrictions on transfer contained in this Section 7. Any such transfer shall be accompanied by a transferor
assignment substantially in the form attached to this Warrant as Exhibit B (the “Transferor
Assignment”), executed by the transferor and the transferee and submitted to the Company. Upon receipt of the duly
executed Transferor Assignment, the Company shall register the transferee thereon as the new Holder on the books and records
of the Company and such transferee shall be deemed a “registered holder” or “registered assign” for
all purposes hereunder, and shall have all the rights of the Holder.

 

8.            Warrant
Agent. The Company may, by written notice to the Holder, appoint an agent (a “Warrant Agent”) for the purpose
of issuing shares of Common Stock on the exercise of this Warrant pursuant hereto, exchanging this Warrant pursuant hereto, and
replacing this Warrant pursuant hereto, or any of the foregoing, and thereafter any such issuance, exchange or replacement, as
the case may be, shall be made at such office by such Warrant Agent.

 

9.            Transfer
on the Company’s Books. Until this Warrant is transferred on the books of the Company, the Company may treat the Holder
as the absolute owner hereof for all purposes, notwithstanding any notice to the contrary.

 

10.            Notices.
Any notice required or permitted hereunder shall be given in the manner provided in the subsection titled “Notices”
in the Purchase Agreement, the terms of which are incorporated herein by reference.

 

11.            Supplements
and Amendments; Whole Agreement. This Warrant may be amended or supplemented only by an instrument in writing signed by the
parties hereto. This Warrant, together with the Purchase Agreement and all the other Transaction Documents, taken together, contain
the full understanding of the parties hereto with respect to the subject matter hereof and thereof and there are no representations,
warranties, agreements or understandings with respect to the subject matter hereof and thereof other than as expressly contained
herein and therein.

 

12.            Governing
Law. This Warrant shall be governed by and interpreted in accordance with the laws of the State of Nevada, without giving effect
to the principles thereof regarding the conflict of laws. The Company and, by accepting this Warrant, the Holder, each irrevocably
(a) consent to and expressly submit to the exclusive personal jurisdiction of any state or federal court sitting in San Diego
County, California in connection with any dispute or proceeding arising out of or relating to this Warrant, (b) agree that
all claims in respect of any such dispute or proceeding may only be heard and determined in any such court, (c) expressly
submit to the venue of any such court for the purposes hereof, and (d) waive any claim of improper venue and any claim or
objection that such courts are an inconvenient forum or any other claim or objection to the bringing of any such proceeding in
such jurisdictions or to any claim that such venue of the suit, action or proceeding is improper. The Company and, by accepting
this Warrant, the Holder, each hereby irrevocably consent to the service of process of any of the aforementioned courts in any
such proceeding by the mailing of copies thereof by reputable overnight courier (e.g., FedEx) or certified mail, postage prepaid,
to such party’s address as provided for herein, such service to become effective ten (10) calendar days after such mailing.
THE COMPANY HEREBY IRREVOCABLY WAIVES ANY RIGHT IT MAY HAVE TO, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR THE ADJUDICATION
OF ANY DISPUTE HEREUNDER OR IN CONNECTION WITH OR ARISING OUT OF THIS WARRANT OR ANY TRANSACTION CONTEMPLATED HEREBY.

 

    6

     

    

 

13.            Remedies.
The remedies at law of the Holder of this Warrant in the event of any default or threatened default by the Company in the
performance of or compliance with any of the terms of this Warrant are not and will not be adequate and, without limiting any
other remedies available to the Holder in the Transaction Documents, law or equity, to the fullest extent permitted by law,
such terms may be specifically enforced by a decree for the specific performance of any agreement contained herein or by an
injunction against a violation of any of the terms hereof or otherwise.

 

14.            Counterparts.
This Warrant may be executed in any number of counterparts and each of such counterparts shall for all purposes be deemed to be
an original, and all such counterparts shall together constitute but one and the same instrument. Signature delivered via facsimile
or email shall be considered original signatures for purposes hereof.

 

15.            Descriptive
Headings. Descriptive headings of the sections of this Warrant are inserted for convenience only and shall not control or affect
the meaning or construction of any of the provisions hereof.

 

16.            Attorney’s
Fees. In the event of any litigation or dispute arising from this Warrant, the parties agree that the party who is awarded
the most money shall be deemed the prevailing party for all purposes and shall therefore be entitled to an additional award of
the full amount of the attorneys’ fees and expenses paid by said prevailing party in connection with the litigation and/or
dispute without reduction or apportionment based upon the individual claims or defenses giving rise to the fees and expenses. Nothing
herein shall restrict or impair a court’s power to award fees and expenses for frivolous or bad faith pleading.

 

17.            Severability.
Whenever possible, each provision of this Warrant shall be interpreted in such a manner as to be effective and valid under applicable
law, but if any provision of this Warrant shall be invalid or unenforceable in any jurisdiction, such provision shall be modified
to achieve the objective of the parties to the fullest extent permitted and such invalidity or unenforceability shall not affect
the validity or enforceability of the remainder of this Warrant or the validity or enforceability of this Warrant in any other
jurisdiction.

 

[Remainder of page intentionally
left blank]

 

    7

     

    

 

IN WITNESS WHEREOF,
the Company has caused this Warrant to be duly executed by an officer thereunto duly authorized.

 

Dated:
June 4, 2020

 

	 	THE COMPANY:
	 	 
	 	ELECTROMEDICAL TECHNOLOGIES, INC.
	 	 
	 	By:	                 
	 	Name: Matthew Wolfson
	 	Title:Chief Executive Officer

 

[Signature page to Warrant]

 

     

     

    

 

EXHIBIT A

 

NOTICE OF EXERCISE OF WARRANT

 

TO:         ELECTROMEDICAL
TECHNOLOGIES, INC. 

ATTN:
_______________ 

VIA FAX
TO: (    )______________ 

VIA EMAIL
TO: (    )______________

 

The undersigned hereby irrevocably
elects to exercise the right, represented by the Warrant to Purchase Shares of Common Stock dated as of ________ (the
 “Warrant”), to purchase shares of the common stock, $0.001 par value (“Common Stock”),
of ELECTROMEDICAL TECHNOLOGIES, INC., and tenders herewith payment in accordance with Section 2 of the Warrant, as
follows:

 

	 	 	CASH: $__________________________
    = (Exercise Price x Warrant Shares)
	 	 	 
	 	 	Payment is being made
    by:
	 	 	 
	 	 	_____       enclosed
    check
	 	 	_____       wire
    transfer
	 	 	_____       other
	 	 	 
	 	 	CASHLESS EXERCISE:
	 	 	 

  Net number of Warrant Shares to be issued
to Holder: ______*

 

* X = Y (A-B)

A

 

   Where X =      the
number of Warrant Shares to be issued to Holder.

 

Y =       the
number of Warrant Shares that the Holder elects to purchase under this Warrant (at the date of such calculation).

 

		A	=       the Market Price (at the date of such calculation).

 

		B	=       Exercise Price (as adjusted to the date of such calculation).

 

Capitalized terms used
but not otherwise defined herein shall have the meanings ascribed to them in the Warrant.

 

It is the intention
of the Holder to comply with the provisions of Section 2.2 of the Warrant regarding certain limits on the Holder’s right
to exercise thereunder. The Holder believes this exercise complies with the provisions of such Section 2.2. Nonetheless, to
the extent that, pursuant to the exercise effected hereby, the Holder would have more shares of Common Stock than permitted under
Section 2.2, this notice should be amended and revised, ab initio, to refer to the exercise which would result in the
issuance of the maximum number of such shares permitted under such provision. Any exercise above such amount is hereby deemed void
and revoked.

 

     

     

    

 

As contemplated by
the Warrant, this Notice of Exercise is being sent by facsimile or email to the fax number and officer indicated above.

 

If this Notice of Exercise
represents the full exercise of the outstanding balance of the Warrant, the Holder either (1) has previously surrendered the
Warrant to the Company or (2) will surrender (or cause to be surrendered) the Warrant to the Company at the address indicated
above by express courier within five (5) Trading Days after delivery or email or facsimile transmission of this Notice of
Exercise; provided that the Warrant Shares to be delivered pursuant to this Notice of Exercise have been delivered to the Holder
as of such date.

 

To the extent the Warrant
Shares are not able to be delivered to the Holder via the DWAC system, please deliver certificates representing the Warrant Shares
to the Holder via reputable overnight courier after receipt of this Notice of Exercise (by facsimile transmission or otherwise)
to:

 

		 	 
	 	 	 
	 	 	 

 

	Dated:	 	 

 

	 	

[Name of Holder]

 

	By:	 	

 

     

     

    

 

EXHIBIT B

 

FORM OF TRANSFEROR ENDORSEMENT 

(To be signed only on transfer of the Warrant)

 

For value
received, the undersigned hereby sells, assigns, and transfers unto the person(s) named below under the heading “Transferees”
the right represented by the Warrant to Purchase Shares of Common Stock dated as of _________ (the “Warrant”)
to purchase the percentage and number of shares of common stock, $0.001 par value (“Common Stock”), of ELECTROMEDICAL
TECHNOLOGIES, INC. specified under the headings “Percentage Transferred” and “Number Transferred,”
respectively, opposite the name(s) of such person(s), and appoints each such person attorney to transfer the undersigned’s
respective right on the books of ELECTROMEDICAL TECHNOLOGIES, INC. with full power of substitution in the premises.

 

	Transferees	Percentage Transferred	Number Transferred

 

 

 

Dated:___________,
______

 

	 	 
	 	[Transferor Name must conform to the name of Holder as specified on the face of the Warrant]
	 	 
	 	By:	          

	 	Name:	 

 

Signed
in the presence of:

 

	 	
	(Name)	

 

ACCEPTED
AND AGREED:

 

	 	
	[TRANSFEREE]	

 

	By:	 	 

	Name:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00311-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00311-of-00352.parquet"}]]